Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
- PMID: 12650976
- DOI: 10.1016/s0006-8993(02)04243-9
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
Abstract
An increasing body of evidence indicates that oxidative stress and damage play a role in the pathogenesis of a number of diseases associated with neurodegeneration, including Down syndrome (DS), Alzheimer's disease (AD) and Pick's disease (PD). Although oxidative stress is a common element in these diseases, specific clinico-pathological phenotypes have been described for each disorder. Development of these phenotypes might be linked, among others, to differences in antioxidant response. The present study is designed to investigate expression of peroxiredoxins (Prxs), the newly characterized family of highly conserved antioxidant enzymes, and other antioxidant enzymes in frontal cortex and cerebellum of DS, AD and PD patients using the technique of proteomics. Levels of Prx I, Mn superoxide dismutase (SOD2) and glutathione-S-transferase omega1 in DS, AD and PD were not significantly different from that of controls in both brain regions investigated. In contrast, Prx II was significantly increased (P<0.05) in frontal cortex of DS, AD and PD, whereas Prx III was decreased in frontal cortex of DS (P<0.01) and PD (P<0.001). Interestingly, Prx VI displayed a significant increase (P<0.05) only in PD frontal cortex. The present data indicate that differential regulation of antioxidant enzymes exist in DS, AD and PD, suggestive of the diversity as well as distinct functional roles of these proteins. Moreover, while up-regulation of Prx II appears to provide evidence for the existence of compensatory response in increased cell loss, up-regulation of Prx VI may be used to discriminate PD from AD as well as DS.
Similar articles
-
Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.J Neural Transm Suppl. 2001;(61):223-35. doi: 10.1007/978-3-7091-6262-0_18. J Neural Transm Suppl. 2001. PMID: 11771746
-
Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.J Neural Transm Suppl. 2001;(61):71-84. doi: 10.1007/978-3-7091-6262-0_6. J Neural Transm Suppl. 2001. PMID: 11771762
-
Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease.Brain Res Mol Brain Res. 2005 Jan 5;133(1):1-5. doi: 10.1016/j.molbrainres.2004.09.008. Brain Res Mol Brain Res. 2005. PMID: 15661359
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
-
Peroxiredoxins in the central nervous system.Subcell Biochem. 2007;44:357-74. doi: 10.1007/978-1-4020-6051-9_17. Subcell Biochem. 2007. PMID: 18084903 Review.
Cited by
-
Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.Neurochem Res. 2007 Apr-May;32(4-5):757-73. doi: 10.1007/s11064-006-9203-y. Epub 2006 Dec 27. Neurochem Res. 2007. PMID: 17191135 Review.
-
Up-regulation of Thioredoxin 1 by aerobic exercise training attenuates endoplasmic reticulum stress and cardiomyocyte apoptosis following myocardial infarction.Sports Med Health Sci. 2020 Jul 31;2(3):132-140. doi: 10.1016/j.smhs.2020.07.001. eCollection 2020 Sep. Sports Med Health Sci. 2020. PMID: 35782283 Free PMC article.
-
Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions.Life (Basel). 2021 Mar 22;11(3):262. doi: 10.3390/life11030262. Life (Basel). 2021. PMID: 33810179 Free PMC article. Review.
-
Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats.Front Neuroanat. 2015 Mar 4;9:16. doi: 10.3389/fnana.2015.00016. eCollection 2015. Front Neuroanat. 2015. PMID: 25788877 Free PMC article.
-
Proteomic-Based Studies on Memory Formation in Normal and Neurodegenerative Disease-Affected Brains.Adv Exp Med Biol. 2024;1443:129-158. doi: 10.1007/978-3-031-50624-6_7. Adv Exp Med Biol. 2024. PMID: 38409419 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical